Sonic Healthcare Limited (SKHHY)
OTHER OTC:SKHHY
Want to see SKHHY full AI Analyst Report?
SKHHY Stock Chart & Stats
$14.96
-$0.18(-1.00%)
At close: 4:00 PM EST
$14.96
-$0.18(-1.00%)
Day’s Range― - ―
52-Week Range$13.06 - $18.71
Previous CloseN/A
Volume5.11K
Average Volume (3M)19.70K
Market Cap
$7.01B
Enterprise Value$17.14B
Total Cash (Recent Filing)$556.57M
Total Debt (Recent Filing)$7.34B
Price to Earnings (P/E)18.6
Beta0.43
Next Earnings
Aug 20, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend Yield4.08%
Share Statistics
EPS (TTM)0.81
Shares Outstanding494,237,950
10 Day Avg. Volume29,893
30 Day Avg. Volume19,698
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.57
Price to Sales (P/S)1.35
P/FCF Ratio13.57
Enterprise Value/Market Cap2.45
Enterprise Value/Revenue2.20
Enterprise Value/Gross Profit7.73
Enterprise Value/Ebitda12.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.87
Revenue Forecast (FY)$7.80B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSonic's very strong free cash flow growth and high cash-to-earnings conversion indicate durable internal funding for capex, dividends and selective M&A. Robust FCF reduces refinancing risk and supports capital returns while enabling reinvestment without over-reliance on debt.
Consistent Organic Revenue Growth And Geographic DiversificationSustained c.5% organic growth across multiple markets shows persistent demand for diagnostics. Diversified revenue across Australia, Germany, UK and imaging lowers single-market concentration risk and supports steady volume-led revenue expansion over the medium term.
Margin Resilience, Guidance Reaffirmation And Capital DisciplineModest margin expansion with maintained EBITDA guidance and explicit debt-cover targets signals disciplined operations and conservative capital management. Available headroom and focus on investment-grade balance sheet underpin sustainable dividends and optionality for strategic investments.
Bears Say
U.S. Margin Pressure And RestructuringWeak U.S. performance is a structural concern as lower-margin operations and ongoing restructuring reduce group profitability. Rationalisation of practices carries execution and timing risk, and slow U.S. organic growth limits margin recovery and long-term contribution from a large market.
Billing Disruption Inflated Working Capital And Net DebtProlonged billing/collection disruption shifts cash conversion timing and raises reported leverage, constraining liquidity and capital allocation. Even if transient, delayed collection benefits push cash recovery into later periods and increase refinancing and working-capital management demands.
Acquisition-related Margin Dilution And Higher Near-term CapexRecent deals and property transactions have diluted near-term margins and raised reported capex and net debt. Integration and fit-out spending can compress returns and increase leverage in the medium term until synergies and property monetisation materialise, adding execution risk.
Sonic Healthcare News
SKHHY FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest stock price was $13.06 and its highest was $18.71 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is $7.01B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 54 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported $0.353 earnings per share for the quarter, missing the consensus estimate of $0.357 by -$0.004.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Overvalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of $0.316 which represents an annual dividend yield of 4.08%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.48.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of $0.353 in its last earnings report, missing expectations of $0.357. Following the earnings report the stock price went up 9.657%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in SKHHY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.48%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
19.27%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.
SKHHY Company Deck
SKHHY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Overall the call presents a largely positive operational and financial picture: strong H1 results (revenue, EBITDA, net profit), maintained full-year EBITDA guidance, margin improvement at group level (+30 bps), successful integration progress in major acquisitions (Germany LADR and Swiss deals), and continued organic growth across several markets (Australia, Germany, UK, Radiology). Offsetting these positives are concentrated challenges in the U.S. (margin pressure, restructuring and delayed revenue collection benefits), elevated short-term net debt and working capital due to acquisitions and the Change Healthcare billing disruption, FX headwinds for H2, and some regulatory/wage uncertainties (Germany GOA reform and Australian Fair Work outcomes). Management has clear remediation and capital management plans (operating review, sale-and-leaseback program, potential buybacks) and has retained guidance, supporting a constructive outlook despite identifiable near-term risks.View all SKHHY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---